Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Surgical Research|January 21, 2023
Characterization of Combined Blast- and Fragment-Induced Pelvic Injuries and Hemostatic Resuscitation in RabbitsZhao Ye, Zhaowen Zong, Xin Zhong, et al.
Biomolecules & Biomedicine|February 22, 2024
Donor-derived cell-free DNA as a diagnostic marker for kidney-allograft rejection: A systematic review and meta-analysisYanbo Xing, Qiang Guo, Cong Wang, et al.
Military Medicine|July 17, 2021
Method for Teaching Life-Saving Combat First-Aid Skills With live-actor Patients Using a Wearable Training ApparatusMinrui Lv, Yijun Jia, Zhaowen Zong, et al.
Cancer Epidemiology|February 14, 2013
Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studiesYijun Jia, Yunshu Lu, Kejin Wu, et al.
Plos One|September 23, 2024
Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor XenograftsQing Chen, Ziyi Weng, Yunshu Lu, et al.
Plos One|January 4, 2017
An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor XenograftsQing Chen, Ziyi Weng, Yunshu Lu, et al.
Annals of Palliative Medicine|July 15, 2021
Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature reviewYukai Chen, Yijun Jia, Qinghua Liu, et al.
Plos One|August 5, 2014
Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatmentYongkun Wang, Chuanying Wang, Yijun Jia, et al.
Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi|August 14, 2024
Empirical and modified hemostatic resuscitation for liver blast injury combined with seawater immersion: A preliminary studyHaoyang Yang, Chenglin Dai, Dongzhaoyang Zhang, et al.
Frontiers in Oncology|September 28, 2020
Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With <i>EGFR</i> MutationsYijun Jia, Xuefei Li, Chao Zhao, et al.
Pageof 5